• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-09-16

  Oh et al. establish a scalable human iPSC-derived sensory-neuron system that reproduces defining molecular features of HSV-1 latency and supports reactivation experiments. The model provides a human-relevant platform for studying neuron-intrinsic latency mechanisms while clarifying which conclusions remain specific to an in vitro neuronal system.

• PRINT: RNA-Mediated Safe-Harbor Transgene Insertion

  2026-09-16

  The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to insert transgenes into a multicopy human safe-harbor locus through target-primed reverse transcription. Its results show that direct cDNA synthesis can produce substantial full-length transgene insertion in cultured human primary cells while avoiding extrachromosomal donor DNA.

• Zwitterionic Lipids Improve mRNA Cancer Vaccines

  2026-09-15

  A Nature Biomedical Engineering research briefing describes how membrane-destabilizing zwitterionic (MeDZ) lipids can improve mRNA expression while reducing local reactogenicity in lipid nanoparticle cancer-vaccine models. The design uses a pH-responsive PyCB headgroup to promote endosomal escape without maintaining a strongly cationic state under physiological conditions.

• 3-Deazaadenosine hydrochloride: Assay Logic

  2026-09-15

  3-Deazaadenosine hydrochloride is a selective S-adenosylhomocysteine hydrolase inhibitor for interrogating methylation-dependent biology. This guide develops a causal assay framework that separates metabolic perturbation, m6A regulation, RNA stability, and hepatic stellate cell phenotypes.

• Oligo (dT) 25 Beads for mRNA Workflows

  2026-09-14

  Build faster polyA-tail capture workflows for intact eukaryotic mRNA, from total RNA cleanup to first-strand cDNA synthesis and sequencing library preparation. This practical guide connects APExBIO magnetic bead handling with the NSD1–PPARγ–PTEN axis in endometrial cancer research, emphasizing assay design, recovery, and troubleshooting.

• Vorinostat (SAHA, MK0683) Assay Guide

  2026-09-14

  A scenario-driven guide to using Vorinostat (SAHA, MK0683), SKU A4084, in cell viability, proliferation, and apoptosis workflows. It connects HDAC potency, formulation, assay design, and interpretation to practical laboratory decisions supported by product data and cited research.

• Reactive Oxygen Species Assay Kit: DHE Guide

  2026-09-13

  Build a controlled live-cell superoxide workflow for oxidative stress assay, apoptosis research, and redox signaling studies. This guide shows how to turn DHE fluorescence into a reproducible relative readout while avoiding overinterpretation of total ROS or pathway causality.

• Propidium Iodide: DNA Intercalating Dye Guide

  2026-09-12

  Propidium iodide is a membrane-impermeant DNA intercalating dye for cell viability assay, apoptosis detection, and cell cycle analysis. Its fluorescence reports nucleic-acid access and membrane compromise, but PI alone does not identify a specific death mechanism.

• 0.4% Trypan Blue Solution: Practical Guide

  2026-09-11

  0.4% Trypan Blue Solution supports rapid cell viability measurement and live/dead cell discrimination by staining membrane-damaged cells blue while viable cells remain unstained. It is intended for research cell counting and cytotoxicity workflows, not for diagnostic, clinical, or medical use.

• JNJ-26481585 (Quisinostat) Cancer Workflows

  2026-09-11

  Build reproducible HDAC inhibition experiments around JNJ-26481585 (Quisinostat), from DMSO stock preparation and dose-response testing to apoptosis, ERK1/2, and TRIM21 readouts. The workflow connects epigenetic modulation with pituitary adenoma drug-resistance research while highlighting practical controls, formulation limits, and troubleshooting decisions.

• MALAT1, TDP-43, and RNA-Binding Control

  2026-09-10

  This 2025 Journal of Biological Chemistry study identifies MALAT1 abundance as a functional regulator of TDP-43 activity, rather than merely a correlated marker of neuronal disease. By connecting MALAT1 perturbation with cell survival and altered TDP-43 binding to mRNA, the work provides a mechanistic framework for studying noncoding RNA–protein networks in neurodegeneration models.

• Streptavidin-FITC for Biotin Detection

  2026-09-10

  Streptavidin-FITC is a fluorescein isothiocyanate conjugated streptavidin reagent for fluorescent detection of biotinylated antibodies, proteins, nucleic acids, and other biomolecules. Its tetrameric architecture supports high-affinity biotin capture, while FITC provides fluorescence near 488 nm excitation and 520 nm emission for microscopy and flow cytometry workflows.

• HyperFluor 488: Smarter IgG Assays

  2026-09-09

  Discover how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody supports sensitive, interpretable fluorescence assays. This guide connects secondary-antibody design with practical decisions for vaccine, serology, imaging, and translational workflows.

• Disentangling Growth Arrest from Cell Death

  2026-09-09

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. By separating proliferative arrest from cell killing and considering their timing, the study provides a more precise framework for interpreting drug-response experiments and designing follow-up assays.

• Cy5-UTP for Spatial RNA Mechanism

  2026-09-08

  Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH, multiplexed expression analysis, and mechanistic studies of RNA localization. This article presents an assay-design framework connecting Cyanine 5-uridine triphosphate labeling with the GADD34–G3BP1 stress-response mechanism reported in SARS-CoV-2 research.

546 records 4/37 page Previous Next 12345 下5页 Last page